How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The application is where the business logic lives, where sensitive data is handled, and where an attacker who gets in has the ...

Companies blame tariffs, energy prices and demand from AI data centers, raising concerns that inflation above the Fed’s target rate could persist. Fed Chair Kevin Warsh named venture capitalist Marc ...

Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded funds. Nick has previously held Series 7 and Series 66 licenses and has ...

A macOS ClickFix campaign shifted tactics from openly serving infostealer lures to hiding them behind a browser-fingerprinting gate. The change makes malicious infrastructure harder to detect while ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.